Search results
Market Today: Eli Lilly's Tirzepatide Success, AeroVironment Fac
Guru Focus· 11 hours agoThe market showed mixed action on this quadruple witching options expiration day, leading to...
New JAK 1 Inhibitor Proves Promising in Phase 3 RA Trial
Medscape· 3 days agoThe highly selective oral Janus kinase (JAK) inhibitor SHR0302 (ivarmacitinib) enables more patients...
Intra-Cellular depression drug succeeds in second late-stage study
BioPharma Dive via Yahoo Finance· 4 days agoThe results position the company to unlock what’s believed to be a multibillion-dollar sales...
ASCO 2024: How to Best Use New Breast Cancer Data
Medscape· 2 days agoKevin Kalinsky and Sara Hurvitz discuss the results of awaited data in the breast cancer space presented at the 2024 ASCO Annual Meeting.
Stroke Risk Scale Helps ID Candidates for Anticoagulation
Medscape· 5 days agoA common stroke risk calculator can help electrophysiologists and cardiologists distinguish which...
Radioactive drugs strike cancer with precision
Ars Technica· 23 hours agoOn a Wednesday morning in late January 1896 at a small light bulb factory in Chicago, a middle-aged woman named Rose Lee found herself at the heart of a...
Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial
Medscape· 3 days agoThe primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce...
Top Studies From ESOC 2024 in Review
Medscape· 3 days agoMedscape NeurologyDiener on NeurologyCOMMENTARYTop Studies From European Stroke Organisation Congress 2024 in ReviewHans-Christoph Diener, MD, PhD...
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials...
Morningstar· 5 days agoFN Media Group News Commentary - According to a report from Mordor Intelligence the Acute Myeloid Leukemia Market size is estimated at USD 1.83 billion in 2024, and is expected to reach USD ...
Investors flock to investment grade debt markets | JD Supra
JD Supra· 1 day agoIn the US, investment grade corporate borrowers secured US$429.7 billion of financing in Q1 2024; the highest level of quarterly issuance since Q2 2020, according to S&P Global. European investment ...